Ablacon Company
Ablacon is a provider of AI-guided atrial fibrillation therapies.
Technology:
['BioTech & HealthTech']
Headquarters:
Wheat Ridge, Colorado, United States
Founded Date:
2015
Last Funding Type:
Post-IPO Equity
Investors Number:
7
Estimated Revenue:
$50M to $100M
Total Funding:
$6.8B
Industry:
Med Tech
Investor Type:
contact@ablacon.com